Vor Biopharma Earnings Estimate
| VOR Stock | USD 0.90 0.08 9.76% |
Vor |
Vor Biopharma Earnings per Share Projection vs Actual
About Vor Biopharma Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Vor Biopharma earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Vor Biopharma estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Vor Biopharma fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -306.1 M | -290.8 M | |
| Retained Earnings Total Equity | -200 M | -210 M | |
| Earnings Yield | (0.90) | (0.85) | |
| Price Earnings Ratio | (1.15) | (1.21) | |
| Price Earnings To Growth Ratio | 0.06 | 0.06 |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.